Identification of Molecular Compounds Targeting Bacterial Propionate Metabolism with Topological Machine Learning
Astrit TolaiD, Shan Aziz, Dannie Zhabilov, Duane David WinkleriD, Mehmet CandasiD, Baris CoskunuzeriD
Abstract
This study demonstrates the effective integration of comparative protein sequence analysis with novel topological machine learning methods to tackle a key issue in computational biology: identifying potential inhibitor compounds for methylcitrate dehydratase--an enzyme essential to the methylcitrate pathway in bacteria and fungi. While many ML models have proven effective on benchmark datasets, we applied these techniques specifically to discover compounds for this target protein. This pathway, crucial for metabolizing propionic acid, is essential in pathogenic bacteria for utilizing host-derived lipids and amino acids, making it a promising antimicrobial target. Inefficient removal of propionate can lead to toxic accumulation, threatening microbial survival. In our research, we utilize the latest methods in topological machine learning, multiparameter persistence, to transform the molecular structure of potential compounds into topological vectors for ligand-based drug discovery. By applying our tailored topological model, we prioritized 15 compounds with promising characteristics for inhibiting the active site of methylcitrate dehydratase. Computational molecular docking simulations reveal that these identified compounds interact with key amino acid residues critical to the enzymes function. Our findings underscore the power of integrating topology-based modeling with comparative sequencestructure-function analysis and ligand docking. Considering compounds geometric fit, energy, and interaction profiles enhances predictions and guides the design of optimized new compounds. This refined approach offers a solid foundation for lead optimization, representing the most promising molecular scaffolds for modification, advancing compound discovery, and providing valuable insights into binding interactions for further experimental validation and potential drug development. Our code is available at https://github.com/AstritTola/Molecular-Compounds-Targeting
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- FWCI
- 0.00
- Field percentile
- 6th percentile
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- In-silico Exploration of Drug Leads Targeting Mycobacterial Ag85C
Katewad Raghavendra Singh, C. M. Anuradha, Chitta Suresh Kumar·bioRxiv·Oct 1, 2026
- BacPROTACs outperform inhibitors in Mycobacterium tuberculosis
David A Brown, Joshua J. Davies, … Francesca Ester Morreale·bioRxiv·Jun 12, 2026
- Phenotypic screening of covalent compound libraries identifies chloromethyl ketone antibiotics and MiaA as a new target
Yizhen Jin, Sadhan Jana, … Hening Lin·Cell chemical biologyPeer-reviewed·Feb 27, 2025
- In silico identification of novel chemical compounds with anti-TB potential for the inhibition of InhA and EthR from Mycobacterium tuberculosis
Sajal Kumar Halder, Fatiha Elma·Journal of Clinical Tuberculosis and Other Mycobacterial DiseasesPeer-reviewed·May 25, 2021
- Identification of Novel Marine-based Inhibitors against Tetracycline Destructase in Acinetobacter Baumannii using Computational Approaches
Sathish Kumar Marimuthu, Pratima Chockalingam, … Vigneshwar Ramakrishnan·bioRxiv·Jun 8, 2025
- High-Throughput Screening Reveals Potential Inhibitors Targeting Trimethoprim-Resistant DfrA1 Protein in Klebsiella pneumoniae and Escherichia coli
Soharth Hasnat, Soaibur Rahman, … Tofazzal Islam·bioRxiv·Nov 18, 2024